Factors responsible for development from normal glucose tolerance to isolated postchallenge hyperglycemia

被引:57
作者
Suzuki, H
Fukushima, M
Usami, M
Ikeda, M
Taniguchi, A
Nakai, Y
Matsuura, T
Kuroe, A
Yasuda, K
Kurose, T
Seino, Y
Yamada, Y
机构
[1] Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Sakyo Ku, Kyoto 6068507, Japan
[2] Ikeda Hosp, Hyogo, Japan
[3] Kansai Denryoku Hosp, Osaka, Japan
[4] Kyoto Univ, Coll Med Technol, Kyoto 606, Japan
[5] Kansai Hlth Management Ctr, Osaka, Japan
关键词
D O I
10.2337/diacare.26.4.1211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - isolated postchallenge hyperglycemia UPH), defined as fasting plasma glucose (FPG) level <7.0 mmol/l and 2-h plasma glucose (PG) level ≥ 11.1 mmol/l, is a subtype of early-stage diabetes. This study evaluates the metabolic profiles of insulin secretion and insulin sensitivity in IPH to clarify the factors responsible for development of this form of type 2 diabetes. RESEARCH DESIGN AND METHODS - We conducted cross-sectional analysis of 231 Japanese men aged 20-70 years. The subjects were classified into the following three groups, based on the results of a 75-g oral glucose tolerance test (OGTT): 1) normal glucose tolerance (NGT), defined as FPG level <6.1 mmol/l and 2-h PG level <7.8 mmol/l (n = 89); 2) impaired glucose tolerance (IGT), defined as FPG level <7.0 mmol/l and 2-h PG level of 7.8-11.1 mmol/l (n = 94); and 3) IPH (n = 48). We compared the three groups for insulin secretion (insulinogenic index) and insulin sensitivity (index of insulin resistance using homeostasis model assessment [HOMA-IR]). RESULTS - The insulmogenic index in IPH was the lowest of the three groups (P < 0.001 versus NGT). The HOMA-IR in the IGT and IPH groups were significantly higher than in the NGT group (P < 0.001), but both were similar. By linear regression analysis, the insulinogenic index rather than fasting insulin or HOMA-IR was the more significant factor in the 2-h PG level in IGT and IPH. CONCLUSIONS - Subjects with IPH exhibited distinctly impaired early-phase insulin secretion and only mild insulin resistance, indicating that reduced insulin secretion is the primary determinant of deterioration from NGT to IGT and IPH in development of type 2 diabetes in these subjects.
引用
收藏
页码:1211 / 1215
页数:5
相关论文
共 30 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]   Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men - The Rancho Bernardo Study [J].
Barrett-Connor, E ;
Ferrara, A .
DIABETES CARE, 1998, 21 (08) :1236-1239
[4]   Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity [J].
Bonora, E ;
Saggiani, F ;
Targher, G ;
Zenere, MB ;
Alberiche, M ;
Monauni, T ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2000, 23 (01) :57-63
[5]   PATHOGENESIS OF NIDDM - A BALANCED OVERVIEW [J].
DEFRONZO, RA ;
BONADONNA, RC ;
FERRANNINI, E .
DIABETES CARE, 1992, 15 (03) :318-368
[6]   POSTCHALLENGE GLUCOSE-CONCENTRATION AND CORONARY HEART-DISEASE IN MEN OF JAPANESE ANCESTRY - HONOLULU HEART PROGRAM [J].
DONAHUE, RP ;
ABBOTT, RD ;
REED, DM ;
YANO, K .
DIABETES, 1987, 36 (06) :689-692
[7]   Reduced β-cell compensation to the insulin resistance associated with obesity in members of Caucasian familial type 2 diabetic kindreds [J].
Elbein, SC ;
Wegner, K ;
Kahn, SE .
DIABETES CARE, 2000, 23 (02) :221-227
[8]   Homeostasis model assessment as a clinical index of insulin resistance - Comparison with the minimal model analysis [J].
Fukushima, M ;
Taniguchi, A ;
Sakai, M ;
Doi, K ;
Nagasaka, S ;
Tanaka, H ;
Tokuyama, K ;
Nakai, Y .
DIABETES CARE, 1999, 22 (11) :1911-1912
[9]   Is reduced first-phase : Insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? [J].
Gerich, JE .
DIABETES, 2002, 51 :S117-S121
[10]   The genetic basis of type 2 diabetes mellitus: Impaired insulin secretion versus impaired insulin sensitivity [J].
Gerich, JE .
ENDOCRINE REVIEWS, 1998, 19 (04) :491-503